The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis

Lin-Bo Gao,Xin-Min Pan,Hong Sun,Xia Wang,Li Rao,Li-Juan Li,Wei-Bo Liang,Mei-Li Lv,Wen-Zhong Yang,Lin Zhang
DOI: https://doi.org/10.1186/1756-9966-29-117
IF: 12.658
2010-01-01
Journal of Experimental & Clinical Cancer Research
Abstract:Background Emerging evidence suggests that ataxia telangiectasia-mutated ( ATM ) is involved in numerous damage repair signaling pathways and cell-cycle checkpoints. Heterozygous carriers of ATM-mutations have an increased risk for the development of breast cancer. The purpose of this study is to evaluate the association between ATM exon39 5557G > A (D1853N, rs1801516) polymorphism and breast cancer susceptibility with the use of a meta-analysis. Methods By searching PubMed and Embase databases, a total of 9 epidemiological studies with 4,191 cases and 3,780 controls were identified. Crude odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) for ATM D1853N polymorphism and breast cancer risk were calculated using fixed- or random-effects model based on the degree of heterogeneity among studies. Results No significant association between the ATM D1853N polymorphism and breast cancer risk was observed in overall analysis (GA versus GG: OR = 1.18; 95% CI, 0.90-1.53; AA versus GG: OR = 0.77; 95% CI, 0.58-1.03; dominant model: OR = 1.16; 95% CI, 0.89-1.51; and recessive model: OR = 0.78; 95% CI, 0.59-1.04, respectively). Conclusion Our results indicate that ATM D1853N polymorphism is not a risk factor for developing breast cancer.
What problem does this paper attempt to address?